NYSE:ZTSPharmaceuticals
How Investors May Respond To Zoetis (ZTS) Pivot Toward High-Value Pet Treatments Amid Fewer Vet Visits
On March 17, 2026, Zoetis CEO and Director Kristin C. Peck presented at the virtual KeyBanc Capital Markets Healthcare Forum, outlining the company’s latest views on the animal health market.
The discussion came as data show pet owners are cutting back on routine vet visits but still paying for higher-value treatments, diagnostics, and medicines when animals become seriously ill, reshaping how companies like Zoetis generate revenue.
Now we’ll explore how resilient spending on high-value pet...